Prefer Newsweek on Google to see more of our trusted coverage when you search. Jim Acosta, the former CNN anchor known for antagonizing President Donald Trump during his first term, did not know what ...

Publishing platform Substack is continuing to invest in video content as it launches the Substack Recording Studio, a built-in mechanism for creators to pre-record and publish videos. The studio, ...

Forbes contributors publish independent expert analyses and insights. Karin Eldor covers entrepreneurs and leaders in fashion & lifestyle. The momentum hasn’t slowed. Every time I went to hit publish ...

Newsletter subscription platform Substack will begin taking advantage of an option on the U.S. App Store that allows users to make purchases outside of Apple’s in-app purchasing system. This ...

Substack, whose text-based subscription platform has reshaped the media business since launching nearly a decade ago, has launched a TV app. The app is in beta and is thus far only available on Apple ...

Jim Acosta, the frequent Donald Trump antagonist who was all but pushed out by CNN earlier this year, may not be the type of person you’d suspect would be a hit on Substack. In fact, when he signed ...

Substack today announced its Substack TV app for Apple TV, which brings video posts and livestreams from the publications users are subscribed to. Here are the details. While Substack is best known as ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Substack hack — what you need to know. When you think of blogging in 2026, especially in ...

Sign up to receive the Vogue Business newsletter for the latest luxury news and insights, plus exclusive membership discounts. Jane Herman, the founder and designer ...

Every time Sydney publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Section 1. Purpose. The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits. This egregious imbalance is ...